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Abstract 
Introduction: N-3 and N-6 
polyunsaturated fatty acids has many 
involvements in activities within or 
entering in regulating various physiological 
processes and in certain pathologies. 
Among systemic physiological effects in 
which they are involved we mention the 
central nervous system development and 
recall of the retina, regulating plasma lipid 
levels, cardiovascular and immune system 
functions, regulating the activity of insulin. 
Material and methods: The experiment 
there were used 60 male Wistar rats , weight 
180 ± 20 grams, procured from the animal 
farm of the Department of 
Pathophysiology, University of Medicine 
and Pharmacy “Gr.T. Popa”, Iaşi. 
Male Wistar rats were divided into two 
study groups: normal control animals (M) 
and test animals. 
Test group was further divided into 
three groups - each group being composed 
of 15 animals. 
Administration of the substances was 
made for 36 weeks (nine months), after 
which the animals were evaluated and 
subsequently sacrificed. 
Results: Following statistical analysis, we 
determined the following: 
• Averages of AGP n3 were significantly 
higher in groups 2 (p <0.001) and 3 (p 
<0.001) compared with group 4  
• Averages ratio n6: n3 in nerve cell 
membrane were significantly lower in 
groups 2  (p <0.001) and 3 (p <0.001) 
compared with group 4  
Discussions: Our experiment 
demonstrates that increased amounts of 
polyunsaturated fatty acids in the 
membranes of nerve cells which can justify 
the positive evolution of animals in 
assessing the performance of concomitant 
behavioral tests. 
Conclusions: This study brings new light 
on the importance of the existence of a 
balance between PUFA intake and daily 
diet. 
Keywords: PUFA, central nervous 
system, lipids profile, mass spectrometry, 
Eicosapentaenoic acid, Docosahexaenoic acid 
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activities within or entering in regulating 
various physiological processes and in 
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physiological effects in which they are 
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system development and recall of the retina,  
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cardiovascular and immune system 
functions, regulating the activity of insulin 
(12, 26). At the level of cellular functions, 
n-3 and n-6 PUFAs has affects over the 
cellular membrane composition and 
function, the synthesis of eicosanoids and 
thus a role in cell signaling, regulation of 
gene expression and regulation of cell 
junctions (12, 24). 
Recent research has shown that the 
deficit of long chain n-3 PUFAs is 
associated with memory loss and decreased 
cognitive functions. Many studies have 
found a correlation between changes in 
quantities of long chain n-3 and n-6 
PUFAs, and changes into the profile of 
these essential fatty acids in neuronal 
membranes (13, 18). It was suspected that 
α-linolenic acid (18:3 n-3) controls 
neuronal membrane composition, theory 
untested so far. Changes into the relative 
quantities of free fatty acids on neuronal 
membrane level may be a key element in 
the physiological role of membranes (6, 25). 
Changes into the composition of long 
chain PUFA diet had effect on function and 
membrane fluidity because they have a role 
in reducing serum cholesterol, cholesterol 
that has a role in controlling membrane 
fluidity and decrease microviscosity of the 
nervous tissue (10, 13, 24). 
Identification of predisposing risk factors 
for both the deficit of the central nervous 
system development and neurodegenerative 
pathologies developing increasing incidence 
in the last period, especially modulation of 
protective factors through nutritional 
supplements can make an outstanding 
attitude in order to find a therapeutic 
method to prevent, delay or improve the 
central nervous system diseases and their 
possible complications (11, 26). 
Material and methods 
The experiment there were used 60 male 
Wistar rats, weight 180 ± 20 grams, 
procured from the animal farm of the 
Department of Pathophysiology, University 
of Medicine and Pharmacy “Gr T. Popa”, 
Iaşi. 
Male Wistar rats were divided into two 
study groups: normal control animals (M) 
and test animals (T) (14, 16). 
Test group was further divided into 
three groups - each group being composed 
of 15 animals, compared with the type of 
substance administered as follows: 
-  Group 1 - male white Wistar rats, 
aceticysteine (ACC) intraperitoneal 
administration of 35 mg/100 g animal; 
- Group 2 - male white Wistar rats 
intraperitoneal administration of PUFA 50 
mg/100 g animal; 
- Group 3 - male white Wistar rats, ACC 
intraperitoneal administration of 35 mg/100 
g animal and PUFA 50 mg/100 g animal; 
Control group contained one group of 
15 animals that received only normal diet 
without further intervention. 
-Group 4 - male white Wistar rats, 
normal diet; (6, 12, 24) 
Administration of the substances was 
made for 36 weeks (nine months), after 
which the animals were evaluated and 
subsequently sacrificed. The animals were 
evaluated through the Morris radial maze 
and multiple T maze.  
The Morris water maze is a large round 
tub of opaque water (made white with 
powdered milk) divided by eight radial 
arms and a hidden platform located 1-2 cm 
under the water's surface in one of the 
arms. The rat was placed on in the center of 
the maze. The rat has to swim in the maze’s 
arms until it finds the other platform to 
stand on. We measured how long it takes 
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for a rat to find hidden platform (12, 16). 
The multiple T-maze is a complex maze 
made of many T-junctions. Performance in 
the multiple T-maze is easy to measure 
because each intersection is identical and 
has a clear right or wrong answer. Multiple 
T-mazes were used to answer questions of 
place vs. response learning and cognitive 
maps. We recorded the time needed for the 
rat to find the end of the maze (12, 16). 
In both tests we found significant 
improvement in learning the mazes for the 
rats that received n3 PUFAs via 
intraperitoneal administration. 
Also we monitored biochemical 
(glycemic profile, lipids profile and 
oxidative stress parameters such as 
Malondialdehyde, Glutathione Peroxidase, 
and Total Antioxidant Capacity) and 
zoometrical (weight, length) parameters 
which showed significant variations for the 
animals that received PUFA n3 treatment. 
Brain lipid profile of Wistar rats was 
carried out using mass spectrophotometry 
liquid chromatography. Results were 
obtained using Agilent 6500 Series system 
Accurate-Mass Quadrupole Time-of-Flight 
(Q-TOF) LC / MS (4, 5, 24). 
The samples were separated on a reverse 
phase column Zorbax SB-C18 (4.6 x 150 
mm, 5 mm). Mobile phase consists of H2O 
with 0.1% formic acid (solvent A) and 
acetonitrile with 0.1% formic acid (solvent 
B) filtered and degassed before use (2, 6, 16). 
The following gradient program was 
used: 95% to 100% solvent B in 10 minutes, 
maintaining 100% B up to 25 minutes, then 
return to 95% B, the total registration was 
60 minutes. Were injected 10 ml of the 
sample (dissolved in isopropanol: 
acetonitrile 1:1) at a rate of 1ml/minut (18, 
19 , 26). 
UV-VIS DAD detector was monitored 
between 190-900nm. LC system was 
directly connected to the electrospray 
ionization source (ESI) of mass 
spectrometry. Terms of the Q / TOF MS 
selected were: ESI in positive mode, drying 
gas flow (N2) 7L/min , gas temperature 325 
º C, nebuliser pressure 35 psig, capillary 
voltage 4000 V,  200 V fragmentation 
voltage, the compounds have been 
investigated on the m / z 100-1500 (16, 17). 
Results 
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Figure 1  Mass spectrum of type of formed ions - AG in the brain 
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Table I 
Interpretation of mass spectrum for the types of formed ions 
P1_7,151 min X   DAD 
m/z Abund Charge  
228.31795 33198  9-Tetradecenoic acid / [M+H+]+ 
272.37584 8676  Palmitoleic acid sau cis-6-Hexadecenoic acid / [M+NH4+]+ 
282.36794 91847 1 Oleic acid sau Elaidic acid / M 
283.37284 16569 1 Oleic acid sau Elaidic acid / [M+H+]+ 
287.32845 11087   
300.39192 62818 1 Linoleic acid /[M+NH4+]+ + (H) ori Stearidonic acid / [M+Na+]+ + (H) 
301.39546 11648 1 Gamma-linolenic acid, GLA or α-Linolenic acid / [M+Na+]+ or Oleic acid or Elaidic 
acid / [M+NH4+]+ 
305.35397 105383 1 Arachidonic acid / [[M+H+]+ori Oleic acid sau Elaidic acid / [M+Na+]+ 
306.35547 20256 1 Dihomo-γ-linolenic acid / M 
316.43518 11386   
322.39191 11848  Eicosapentaenoic acid / Eicosapentaenoic acid 
327.35176 117434 1 Arachidonic acid / [M+Na+]+ 
328.35426 25140 1 Docosahexaenoic acid / M 
343.33098 109164 1  
344.33403 20977 1  
349.35166 13684   
403.46611 7813   
 
Table II 
Membrane polyunsaturated fatty acid 
composition 
Brain % from the total quantity of fat 
acids 
 Group 1 Group 2 Group 3 Group 4 
n6 PUFAs 30.6 37.2 34.1 39.2 
Linoleic acid 10.1 12.4 10.2 13.8 
Arahidonic acid 17.2 20.8 20.1 21.2 
n3 PUFAs 8.6 10.9 11.2 9.2 
α linoleic acid 2.0 2.2 2.3 2.5 
Eicosapentaenoic 
acid 
1.8 2.8 2.8 1.8 
Docosahexaenoi
c acid 
4.8 5.9 6.1 4.9 
N3: N6 report 3.6 3.4 3.0 4.2 
 
Following statistical analysis, we 
determined the following: 
• averages of AGP n3 were significantly 
higher in groups 2 (p <0.001) and 3 (p 
<0.001) compared with group 4 (19) 
• averages ratio n6: n3 in nerve cell 
membrane were significantly lower in 
groups 2 (p <0.001) and 3 (p <0.001) 
compared with group 4 (1, 3). 
Discussions 
Approximately 20% of the dry weight of 
brain is represented by the long-chain 
polyunsaturated fatty acids which are 
incorporated into the phospholipids, 
substances with a major role for the 
structural integrity of neuronal membrane, 
membrane fluidity, and other associated 
membranes functions, such as receptors, 
enzymes, ion channels and eicosanoid-type 
functions (4, 12, 13, 24). 
The beneficial effects of long-chain 
polyunsaturated fatty acids are directly 
related to their action on neuronal 
membrane composition and fluidity of the 
central nervous system and the 
supplementation in elongated and 
desaturate derivatives with subsequent 
activation of brain conversion and storage 
has proven to be effective (23, 24). Thus α-
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linolenic acid (18:3 n-3) is a source of 
acetate for de novo synthesis of palmitic 
acid and α-linolenic acid (18:3 n-3), 
essential for membrane integrity (6, 8, 9). 
From our study we have observed that 
animal subjects from group 4 (control) had 
increased levels of n6 PUFAs in the brain 
tissue compared to groups 1 (ACC), 2 
(PUFA) and 3 (ACC+PUFA). The lowest 
brain tissue levels of n6 PUFAS were 
recorded in group (ACC), these results may 
be explained by the anti-inflammatory 
effect of acetylcysteine (26). 
The data we have obtained has similar 
behavior for the linolenic and Arachidonic 
acids in the brain tissue (the most common 
n6 PUFAs in the brain) and this is 
consistent with data obtained by other 
studies (3, 4, 11). The levels of n6 PUFAs 
registered by group 3 (ACC+PUFA) are 
higher than in group 2 (PUFA), 
observation that contradict in some matter 
by findings of other researchers (20, 21) and 
can be attributed to different absorption of 
test substances when administrated 
simultaneous via peritoneum.  
The highest concentration of n3 PUFAs 
(known for their anti-inflammatory, 
atherosclerosis prevention and membrane 
fluidity increase effects) in the brain tissue 
were recorded in group 3 (ACC+PUFA) as 
expected. These findings are similar to the 
data encountered in other studies (11, 14, 
21).  
The most significant increase for a single 
fatty acid was recorded for the 
docosahexaenoic acid (DHA), in amount of 
more than 20% and also significant increase 
levels of eicosapentaenoic acid (EPA) were 
recorded for groups 2 (PUFA) and 3 
(ACC+PUFA) but no change in group 1 
(ACC). The peritoneal administration of 
salmon oil, rich source of PUFAs lead to 
increase neuronal deposits of DHA an EPA 
as shown by similar studies (20, 21, 25). 
The use of new and improved methods 
of measuring of lipids in tissues and cells 
created a new, cutting edge, research 
domain called lipidomics. Lipidomics may 
be defined as the large-scale study of 
pathways and networks of cellular lipids in 
biological systems[ The word "lipidome" is 
used to describe the complete lipid profile 
within a cell, tissue or organism. 
Lipidomics is a relatively recent research 
field that has been driven by rapid advances 
in technologies such as mass spectrometry 
(MS), nuclear magnetic resonance (NMR) 
spectroscopy, fluorescence spectroscopy, 
dual polarisation interferometry and 
computational methods, coupled with the 
recognition of the role of lipids in many 
metabolic diseases such as obesity, 
atherosclerosis, stroke, hypertension and 
diabetes (27). 
Lipidomics research involves the 
identification and quantization of the 
thousands of cellular lipid molecular species 
and their interactions with other lipids, 
proteins, and other metabolites. 
Investigators in lipidomics examine the 
structures, functions, interactions, and 
dynamics of cellular lipids and the changes 
that occur during perturbation of the 
system. In lipidomic research, a vast 
amount of information quantitatively 
describing the spatial and temporal 
alterations in the content and composition 
of different lipid molecular species is 
accrued after perturbation of a cell through 
changes in its physiological or pathological 
state. Information obtained from these 
studies facilitates mechanistic insights into 
changes in cellular function. Therefore, 
lipidomic studies play an essential role in 
defining the biochemical mechanisms of 
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lipid-related disease processes through 
identifying alterations in cellular lipid 
metabolism, trafficking and homeostasis 
(27). 
Analysis of brain lipid composition is a 
new and important subject of study but the 
number of studies at present time is scarce 
due to the expensive methods and 
procedures applied to biological material 
and reduced availability of specific 
measuring equipment. Mass spectroscopy 
combined with liquid chromatography 
aimed at the n3 and n 6 PUFAs lipid 
fractions of the brain represent the leading 
wave in the scientific approach to the 
understanding the basic foundations and 
the superior functions of the brain. 
During our research we have also 
investigated the learning performance of 
the animal subjects in two different devices 
(radial Morris maze and the multiple T) 
and the data we acquired shown that the 
rats performance improvement was 
consistent with the increase of brain tissue 
levels of n3 PUFAs for groups 2 (PUFA) 
and 3 (ACC+PUFA). The shortest average 
time needed for the rats to complete both 
mazes was recorded by group 3 
(ACC+PUFA) and the longest for group 4 
(control). Group 2 (PUFA) also had 
average times close to group 3 but the 
difference was not statistically significant. 
Moderate improvement was recorded also 
in group 1 rats (ACC).  
Our experiment it demonstrates 
increased amounts of polyunsaturated fatty 
acids in the membranes of nerve cells 
which can justify the positive evolution of 
animals in assessing the performance of 
concomitant behavioral tests (5, 22). 
Also included in our study were the 
blood lipid profile and oxidative stress 
evaluation. Cholesterol and triglyceride 
blood levels were significantly decreased in 
groups 2 (PUFA) and group 3 
(ACC+PUFA) and oxidative stress 
markers (MDA, GPx and TAC) also 
registered significant lower levels for these 
groups. The zoometric parameters 
recorded, length and weight had average 
values higher for groups 1 (ACC), 2 
(PUFA) and 3 (ACC+PUFA) compared to 
group 4 (control). 
Conclusions 
Peritoneal administration of salmon oil 
rich in PUFAs determined an increase in 
brain tissue deposits of DHA and EPA, fact 
demonstrated trough the mass spectroscopy 
combine with liquid chromatography. 
Mass spectroscopy combined with liquid 
chromatography is a valuable and relevant 
mean to the assess brain lipid 
concentration, but it is time consuming and 
expensive. 
The brain n6 PUFA concentration 
decreased in animals that received only 
acetylcysteine via peritoneum, which can 
indicate a hipolipemiant effect; also blood 
levels of cholesterol and triglycerides were 
lower. 
The increased measured levels of n3 
PUFAs in brain tissue overlapped the 
increased performance measured in the 
previous behavioral experiment 
This research makes an important 
contribution to the study of polyunsaturated 
fatty acids and the importance of placing 
them in the daily diet. Thus, by improving 
the diet with polyunsaturated fatty acids we 
can improve cognitive performance and helps 
prevent or ameliorate certain neurological 
diseases such as Parkinson or Alzheimer 
disease compared with normal diet, low in 
these acids. 
The need for widespread use of 
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polyunsaturated fatty acids is proven by 
many scientific experiments and the results 
obtained in experimental animals. 
This study brings new light on the 
importance of the existence of a balance 
between PUFA intake and daily diet. 
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